Compare AVXL & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVXL | FBIZ |
|---|---|---|
| Founded | 2004 | 1909 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.9M | 437.9M |
| IPO Year | 2013 | 2012 |
| Metric | AVXL | FBIZ |
|---|---|---|
| Price | $4.19 | $52.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $22.00 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 826.5K | 24.4K |
| Earning Date | 02-09-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | N/A | ★ 14.23 |
| EPS | N/A | ★ 5.94 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.69 |
| Revenue Next Year | N/A | $8.47 |
| P/E Ratio | ★ N/A | $8.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.86 | $42.18 |
| 52 Week High | $13.99 | $60.54 |
| Indicator | AVXL | FBIZ |
|---|---|---|
| Relative Strength Index (RSI) | 39.48 | 36.81 |
| Support Level | $3.60 | $46.71 |
| Resistance Level | $5.27 | $53.17 |
| Average True Range (ATR) | 0.27 | 1.76 |
| MACD | -0.04 | -0.13 |
| Stochastic Oscillator | 11.20 | 25.35 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products, including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically, all the business activity functioned through the region of the United States.